Reaction
Myofascial Pain Syndrome reporting signals
As of the last recalculation, Myofascial Pain Syndrome appears in 705 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is DOXEPIN HYDROCHLORIDE (PRR 70.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Doxepin Hydrochloride | 29 | 70.7 | 70.8 |
| Doxepin | 23 | 69.2 | 69.4 |
| Tizanidine Hydrochloride | 22 | 37.1 | 37.1 |
| Carisoprodol | 21 | 33.5 | 33.5 |
| Methylprednisolone Acetate | 8 | 29.8 | 29.9 |
| Hyoscyamine Sulfate | 8 | 26.0 | 26.0 |
| Naproxen | 62 | 25.5 | 25.5 |
| Methocarbamol | 18 | 24.0 | 24.0 |
| Duloxetine | 52 | 23.7 | 23.7 |
| Meloxicam | 38 | 20.4 | 20.4 |
| Sumatriptan | 23 | 18.4 | 18.4 |
| Amphetamine | 4 | 14.3 | 14.4 |
| Ranitidine Hydrochloride | 19 | 10.6 | 10.6 |
| Tapentadol Hydrochloride | 9 | 8.0 | 8.0 |
| Ixazomib | 7 | 7.2 | 7.2 |